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Background: We performed this study to determine the pulmonary capillary permeability (PCP)
measuring radiolabeled human serum albumin leakage into the lung. The objective was to use
PCP to differentiate between cardiogenic and non-cardiogenic pulmonary edema etiologies.
Methods: We conducted this study in 10 patients admitted to the intensive care unit who had
recently developed bilateral pulmonary infiltrates and required hemodynamic monitoring. In
these patients we determined the association among the lung permeability index, cardiac
output, pulmonary capillary wedge pressure, myocardial performance index, and the protein
content of the bronchoalveolar lavage as expressed by bronchoalveolar lavage (BAL) total
protein and BAL-to-serum protein ratio. Twenty mCi of technetium-labeled albumin was in-
jected and measure in the heart and the lung at 10 and 180 min post-injection. Lung and heart
uptake ratios as well as the lung permeability index were calculated.
Results: We found a good correlation between the lung permeability index and both the
myocardial performance index (cardiac output/pulmonary capillary wedge pressure) and the
total protein content of the bronchoalveolar lavage fluid.
Conclusion: The lung permeability index is a feasible, noninvasive estimation of the pulmonary
capillary permeability.
ª 2010 Elsevier Ltd. All rights reserved.3 260 5802; fax: þ1 323 881 8761.
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Pulmonary edema is a leading cause of morbidity and
mortality in the Intensive Care Unit. Many factors are
involved in its pathogenesis such as elevated intravascular
hydrostatic pressure, low colloidosmotic pressure, insuffi-
cient lymphatic drainage, and increased pulmonary capil-
lary permeability.1e5 Daily, physicians face the challenge of
approaching a patient with diffuse pulmonary infiltrates.
Once they have ruled out infection, or hemorrhage, they
must differentiate between cardiogenic and non-cardio-
genic pulmonary edema.
It is customary to make the assumption that there is
insufficient myocardial performance, if upon assessment of
cardiovascular function, one finds the presence of an S3
gallop,amurmur,distended jugular veins, lowcardiacoutput,
elevated central venous pressure or pulmonary capillary
wedge pressure; then the pulmonary capillary permeability is
felt tobenormaland thereby thepulmonaryedema isdeemed
cardiogenic in nature. On the other side of the spectrum, if all
the myocardial performance and fluid status parameters are
normal, it has been hypothesized but no proven that the
culprit of the pulmonary edema is increased pulmonary
capillary permeability and consequently the diagnosis of non-
cardiogenic pulmonary edema is established.
Indeed, there is no gold standard to determinewhether or
not the pulmonary capillary permeability is increased and
therefore, in order to establish the diagnosis of non-cardio-
genic pulmonary edema, one must rule out cardiovascular
etiology and then make the assumption that the pulmonary
capillary permeability is increased. Essentially, there is no
way to directly measure pulmonary capillary permeability;
moreover, when it is assumed that pulmonary capillary
permeability is increased, it is difficult toquantify thedegree
of alteration of the pulmonary capillary permeability.
Non-cardiogenic pulmonary edema is the hallmark of the
acute respiratory distress syndrome (ARDS). It has been
hypothesized that the outburst of cytokines, oxygen free
radicals, and proteolytic enzymes, which are characteristic
of this syndrome, lead to a derangement of the alveolar-
capillary membrane. The intercellular or intracellular pores
increase in number and size, conducing into a leak of
protein and fluid, from the intravascular to the alveolar
space, which in turn will attract more fluid by osmosis into
the alveolar space. This protein flux has been previously
studied using a lung lymph fistula in experimental animal
models.6,7 It has been demonstrated that in conditions of
elevated hydrostatic pressure, there is an increased flow of
a protein-poor fluid into the alveolar space, whereas in
condition of sepsis, such as the one following administra-
tion of live pseudomonas in experimental models of septic
shock, there is an increased flow of a protein-rich fluid.
Due to the inaccessibility of pulmonary lymph in
patients with pulmonary edema, studies were developed
using aspirates from tracheobronchial edema fluid or
bronchoalveolar lavage fluid to determine the protein
content of these fluids and compare them with the plasma
protein content, obtaining ratios such as edema fluid to
plasma protein ratio, and bronchoalveolar lavage fluid to
plasma protein ratio with the objective to find a discrimi-
natory factor to determine if the pulmonary edema was ofcardiogenic nature or due to increased permeability. The
results of these studies revealed that higher values of these
ratios (greater than 0.6) were related to non-cardiogenic
pulmonary edema.8e16
With the same objective, several studies have been con-
ducted using noninvasive radioisotope techniques, based on
the external assessment of radiolabeled protein leakage into
the lung, and allowing a quantitative assessment of the rate
of extravascular protein accumulation and thereby permit-
ting an estimation of the pulmonary capillary permeability
with variable degrees of accuracy.17e21 More recently, Phil-
lips et al proposed that the pulmonary vascular permeability
index (PVPI) [extravascular lung water (EVLW, ml)/pulmo-
nary blood volume (PBV, ml)] may reflect the severity of
acute lung injury.22
The objective of this study was to determine the
usefulness of the lung permeability index as described by
Mishkin et al in discerning between cardiogenic and non-
cardiogenic pulmonary edema as explanation for the
development of diffuse pulmonary infiltrates.
Methods
The study was conducted in patients admitted to the
medical intensive care unit at The University of Texas M. D.
Anderson Cancer Center, who had recently developed
diffuse pulmonary infiltrates of undetermined etiology
upon chest radiographic examination, who had needed
intubation and mechanical ventilator support, and who had
been hemodynamically monitored with a pulmonary artery
catheter. Pregnant women, patients younger than 18 years
of age, patients with chronic heart disease, renal failure,
pneumonia, diffuse alveolar hemorrhage, or neoplastic lung
disease were excluded. The Institutional Review Board
approved the study protocol, and informed consent was
obtained from either the patient or the patient’s surrogate
prior to enrollment in the study.
Procedures
Lung permeability index (LPI)
Intravenous injection of 20 mCi Technetium Tc99 m human
serum albumin (HSA) was administered at minute 0. Ten
minutes later, an Apex 409 MA Elscint portable digital
gamma camera with GAP collimator and a computer for
outlining and analyzing the region of interest (ROI) activi-
ties was centered over the right middle lung field lateral to
the right pulmonary artery and the initial lung uptake was
obtained, then immediately the initial heart uptake was
obtained by placing the camera over the left ventricle.
Both uptake areas measured one square centimeter. At
minute 180, the measurements were repeated and called
the final lung and heart uptake. Because the fluids move
rapidly, it is imperative to make the evaluation during the
first minutes to avoid inaccurate results difficult to eval-
uate.23 The lung permeability index was then calculated by
obtaining the initial and final lung/heart uptake ratios.
Then determining the difference between the final and the
initial lung/heart uptake ratios, and multiplying it by 100.
Table 1 Characteristics of the patients.
Characteristic N[ 10
Mean age (yr) 46.3 16
Sex (no.)
Male 6
Female 4
Race (no.)
White 7
Black 1
Hispanic 2
Clinical Diagnosis
CHF 3
ARDS 7
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Bronchoalveolar lavage (BAL)
Bronchoalveolar lavage was performed after minute 180.
The fiberoptic bronchoscope was inserted and wedged in
the right middle lobe medial segment. Bronchoalveolar
lavage was performed by injecting five 20 ml aliquots of
sterile normal saline solution and retrieving it with the
same syringe. Total protein content was measured and the
measurement was corrected by the dilution factor (Plasma/
Bronchoalveolar lavage urea nitrogen ratio).24
Bronchoalveolar lavage total protein content and urea
nitrogen were measured with colorimetric tests, using
a Johnson & Johnson Vitros 250 Clinical Chemistry Analyzer.
The total protein analysis was based on a modification of
the biuret reaction.25e27 The modification employed is such
that cupric ion (Cuþ2), which binds to an azo dye complex,
is displaced by proteins. The urea nitrogen analysis was
based on the urease method (GLDH),28 using dry multilay-
ered slides.29 The low range limit of urea nitrogen analysis
was 2 mg/dL (0.71 mmol/L urea) for routine use. Specimens
giving urea nitrogen results less than 2 mg/dL were diluted
1:2 with pooled serum having a measured urea nitrogen
value of 13 mg/dL After correction for the dilution factor,
the pooled serum urea nitrogen was subtracted from the
result, yielding a measured value of either 0 mg/dl or 1 mg/
dL. While the analyzer in use measured urea nitrogenTable 2 Results.
PT PCWP CO MPI
1 19 6.43 0.34
2 20 7.19 0.36
3 15 5.18 0.35
4 18 16.8 0.93
5 14 6.72 0.48
6 11 9.18 0.83
7 23 6.74 0.29
8 16 9.2 0.58
9 10 12 1.2
10 25 9.75 0.39concentrations to tenths of a unit, the result was rounded
to, and reported by the analyzer as a whole unit. As a result
of the recovery procedure stated above, a final result of
0 mg/dL indicates an actual urea nitrogen concentration
between 0.0 mg/dL and 0.4 mg/dL, and a result of 1 mg/dL
indicates an actual urea nitrogen concentration between
0.5 mg/dL and 1.4 mg/dL. We assumed a urea nitrogen
value of 0.2 when the urea nitrogen analysis displayed 0.
Statistical analysis
Weused linear regression analysis to evaluate theassociation
between the lung permeability index and the pulmonary
capillary wedge pressure (PCWP), cardiac index (CI),
myocardial performance index (MPI) (MPIZ CI/PCWP), and
bronchoalveolar lavage total proteins, and bronchoalveolar
lavage/plasma total protein ratio.
Results
Ten patients were included in the study and the demo-
graphics are shown in Table 1. All patients had recently
developed respiratory failure and and were intubated and
mechanically ventilated at the time of the lung perme-
ability index determination. At this time, all the pertinent
hemodynamic parameters were obtained. Table 2 discloses
the pulmonary capillary wedge pressure (PCWP), cardiac
output (CO), myocardial performance index (MPI), which
was calculated dividing CO by PCWP and meant the pre-
load-dependent flow, the lung permeability index (LPI), the
bronchoalveolar lavage protein content (BAL.PROT), and
the clinical diagnoses of the 10 patients.
After correcting the diluted bronchoalveolar lavage we
plotted the lung permeability index and the bron-
choalveolar lavage total protein (Fig. 1). It showed that
knowing the lung permeability index we could predict
the protein content of the bronchoalveolar lavage or the
protein leakage into the alveolar space and indirectly
the degree of alteration of the pulmonary capillary
permeability.
Linear regression analysis was performed and we
obtained an R2Z 0.72 (FZ 20.0, p < 0.01) with the
following equation:
Bronchoalveolar lavage
total proteinsZlung permeability index 0:2þ 0:16LPI BAL. PROT. Clinical Diagnosis
12 3.04 CHF
1.6 1.06 CHF
21 3.58 CHF
10.8 2.91 ARDS
27 5.48 ARDS
6.3 1.33 ARDS
6.8 1.43 CHF
5.6 2.88 ARDS
3 1.29 ARDS
14.6 3.92 ARDS
y = 0.2x + 0.16
R2 = 0.72, p<0.01
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Figure 1 Relationship between lung permeability index (LPI) and total protein measured in the bronchoalveolar lavage (BAL).
The lung permeability index 233Similar correlation was found when LPI was plotted
against the BAL/Plasma protein ratio. However, its rela-
tionship was not as significant as the one before (p < 0.05),
The correlation of the lung permeability index with the
cardiac index (CI) and the pulmonary capillary wedge
pressure (PCWP) did not meet statistical significance,
despite of some trend.
However, the correlation between the lung permeability
index and the myocardial performance index (MPIZ car-
diac index/PCWP) was very strong. The linear correlation
with an R2Z 0.91, and p < 0.05 is expressed in the
following formula: MPIZ 0.0042 (LPI)þ 0.13 (Fig. 2).
Discussion
The pathophysiology and management of pulmonary edema
have been widely studied. The most frequent noninvasive
tool clinicians use is the portable supine chest x-ray to
evaluate lung injury, but there are a few studies ques-
tioning its accuracy. Most of radiological studies to assess0
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Figure 2 Correlation between LPI and myocardial performance
capillary wedge pressure.lung water were done not only with posterior-anterior and
lateral views of the chest x-ray, but also with non-portable
equipment. That is why these studies cannot be well
extrapolated to the medical intensive care unit population
where we use portable anterior-posterior view chest x-rays.
Using the fiberoptic bronchoscope it was possible to
evaluate and also obtain cellular samples, but this tech-
nique is too invasive, and moreover there is no specific
cellular finding that could indicate us the degree of lung
injury. Several reports described that the protein concen-
tration index between fluid obtained from injured lungs and
plasma was higher than that obtained from normal
lungs.7e12,30, 31 This leads us to the practice of using
external methods for the detection of tracer protein
equilibration between blood, interstitium, and alveolus,
that could be a useful tool to quantify lung injury.32
At the present time, it is possible to make this quanti-
fication at the bedside and with more accuracy that in the
past. The idea of being less invasive is growing, not only
because it lower the risks for patients, but also because it isy = 0.0042x + 0.13
R2 = 0.91, p<0.05
15 20 25 30
PI
index (MPI) LPIZ lung permeability index. PCWPZ pulmonary
234 A.J. Huaringa et al.less expensive. In the past, physiologists developed many
techniques to have a better understanding of the patho-
physiology of the cardio-respiratory system, but sometimes
these high-risk procedures are not recommended to be used
in critically ill patients.
Although we originally conceptualized the lung
permeability index (LPI) as with discriminatory power to
differentiate cardiogenic pulmonary edema from non-
cardiogenic pulmonary edema, as things steadily went
through we realized that the protein leak into the lungs
is not an on and off phenomenon than rather it is a
continuum.
We had very few cases that turned out to have pure
cardiogenic pulmonary edema with low cardiac output and
low lung permeability index, and very few cases with pure
non-cardiogenic pulmonary edema with high cardiac output
and high lung permeability index. Consequently, we
strongly believe the distinction of cardiogenic pulmonary
edema versus non-cardiogenic pulmonary edema is a utopia
that we do not see frequently in clinical practice.
The measurement of lung permeability index is nonin-
vasive, and also useful at the bedside. It can be used in
critically ill patients, and allows quantification of the
alveolar-capillary membrane leakage, a very good indi-
cator of lung injury. In this study we found that it corre-
lates very well with the protein content in the BAL fluid,
the BAL fluid/plasma protein index and the myocardial
performance index (CI/CPWP), and it could be used as
a surrogate of the measurement of the pulmonary capillary
permeability.
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